Showing results (111-120 of 988) with videos related to
Sort By:
Pageof 99
Clinical and Translational Allergy|March 28, 2022
The SQ HDM SLIT-Tablet is safe and well tolerated in patients with House Dust Mite allergic rhinitis with or without asthma: A "real-life" French studyPascal Demoly, Christophe Leroyer, Elie Serrano, et al.Clinical and Translational Allergy|May 6, 2015
"The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis"Pascal Demoly, Moises A Calderon, Thomas B Casale, et al.Clinical and Translational Allergy|August 26, 2023
Anaphylaxis management in a French pediatric emergency department: Lessons from the ANA-PED studyEvangéline Clark, Luciana Kase Tanno, Tram Vo, et al.Expert Review of Clinical Immunology|January 21, 2016
SQ house dust mite (HDM) SLIT-tablet provides clinical improvement in HDM-induced allergic rhinitisLudger Klimek, Holger Mosbech, Petra Zieglmayer, et al.Asia Pacific Allergy|November 14, 2019
IgE-mediated allergy to proton pump inhibitors with both delayed and immediate onsetLeyla Barakat, Maria João Vasconcelos, Jean Luc Bourrain, et al.Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|March 6, 2015
Evaluation of patients' expectations and benefits in the treatment of allergic rhinitis with a new tool: the patient benefit index - the benefica studyPascal Demoly, Michel Aubier, Frédéric de Blay, et al.International Archives of Allergy and Immunology|May 1, 2015
Clinical relevance of cluster analysis in phenotyping allergic rhinitis in a real-life studyPhilippe Jean Bousquet, Philippe Devillier, Abir Tadmouri, et al.The Journal of Allergy and Clinical Immunology|August 22, 2015
Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trialPascal Demoly, Waltraud Emminger, Dorte Rehm, et al.Clinical and Translational Allergy|June 16, 2012
Comprehensive allergy work-up is mandatory in cystic fibrosis patients who report a history suggestive of drug allergy to beta-lactam antibioticsSilvia Caimmi, Céline Sanfiorenzo, Davide Caimmi, et al.International Journal of Clinical Practice|April 28, 2009
Mometasone furoate: an effective anti-inflammatory with a well-defined safety and tolerability profile in the treatment of asthmaJ BousquetPageof 99